Home ➤ Life Science ➤ Diagnostics ➤ Infectious Disease Molecular Diagnostics Market
Infectious Disease Molecular Diagnostics Market
Published date: Oct 2025 • Formats:
[email protected] +1 718 874 1545
Request Sample Schedule a Call

Table of Contents

Infectious Disease Molecular Diagnostics Market Analysis By Product(Instruments (Benchtop instruments, Portable instruments), Reagents & Kits, Services, Others), By Technology(Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Isothermal Nucleic Acid Amplification Technology (INAAT), Chips & Microarrays, Mass Spectrometry, Sequencing, Transcription Mediated Amplification (TMA), Others), By Application(Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, HPV, Sexually Transmitted Infections, Sepsis, Drug Resistance Diseases, Other Infectious Diseases), By End-User(Hospitals, Clinics and Outpatient Diagnostic Centres, Diagnostic Laboratories, Research Institutes) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

  • Published date: Oct 2025
  • Report ID: 163576
  • Number of Pages: 393
  • Format:
Fact Checked
Infectious Disease Molecular Diagnostics Market https://market.us/report/infectious-disease-molecular-diagnostics-market/
Cite this Research
  • keyboard_arrow_up
    • 1. Executive Summary
      • 1.1. Definition
      • 1.2. Market Snapshot
      • 1.3. Market Overview
      • 1.4. Segment Overview
      • 1.5. Regional Overview
      • 1.6. Competitive Landscape
      • 1.7. Taxonomy
      • 1.8. Industry Voices
    • 2. Global Market Overview
      • 2.1. Global Market Insights and Industry Overview
      • 2.2. Market Dynamics
        • 2.2.1. Drivers
        • 2.2.2. Restraints
        • 2.2.3. Opportunities
        • 2.2.4. Key Infectious Disease Molecular Diagnostics Market Trends
      • 2.3. Technology Landscape
      • 2.4. Regulatory Framework
      • 2.5. Sustainability and ESG (Environmental, Social, Governance)
      • 2.6. Opportunity Map Analysis
      • 2.7. Opportunity Orbits
      • 2.8. PESTLE Analysis
      • 2.9. PORTER’S Five Force Analysis
      • 2.10. Drivers & Restraints Impact Analysis
      • 2.11. Value Chain Analysis
        • 2.11.1. List of Raw Materials Suppliers
        • 2.11.2. List of Infectious Disease Molecular Diagnostics Manufacturers
        • 2.11.3. List of Dealer/Distributors
      • 2.12. Regional Market Share and BPS Analysis
      • 2.13. Impact of Macro-economic Factors/Geopolitical Factors
    • 3. Global Infectious Disease Molecular Diagnostics Market Analysis and Forecast, By Segment, 2020-2034
      • 3.1. Key Findings
      • 3.2. Global Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
      • 3.3. Global Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Product
        • 3.3.1. Instruments
          • 3.3.1.1. Insights
          • 3.3.1.2. Key Takeaways
        • 3.3.2. Reagents & Kits
          • 3.3.2.1. Insights
          • 3.3.2.2. Key Takeaways
        • 3.3.3. Services
          • 3.3.3.1. Insights
          • 3.3.3.2. Key Takeaways
        • 3.3.4. Others
          • 3.3.4.1. Insights
          • 3.3.4.2. Key Takeaways
      • 3.4. Global Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 3.5. Global Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Technology
        • 3.5.1. Polymerase Chain Reaction (PCR)
          • 3.5.1.1. Insights
          • 3.5.1.2. Key Takeaways
        • 3.5.2. In Situ Hybridization (ISH)
          • 3.5.2.1. Insights
          • 3.5.2.2. Key Takeaways
        • 3.5.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
          • 3.5.3.1. Insights
          • 3.5.3.2. Key Takeaways
        • 3.5.4. Chips & Microarrays
          • 3.5.4.1. Insights
          • 3.5.4.2. Key Takeaways
        • 3.5.5. Mass Spectrometry
          • 3.5.5.1. Insights
          • 3.5.5.2. Key Takeaways
        • 3.5.6. Sequencing
          • 3.5.6.1. Insights
          • 3.5.6.2. Key Takeaways
        • 3.5.7. Transcription Mediated Amplification (TMA)
          • 3.5.7.1. Insights
          • 3.5.7.2. Key Takeaways
        • 3.5.8. Others
          • 3.5.8.1. Insights
          • 3.5.8.2. Key Takeaways
      • 3.6. Global Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 3.7. Global Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Application
        • 3.7.1. Respiratory Diseases
          • 3.7.1.1. Insights
          • 3.7.1.2. Key Takeaways
        • 3.7.2. Tuberculosis
          • 3.7.2.1. Insights
          • 3.7.2.2. Key Takeaways
        • 3.7.3. Meningitis
          • 3.7.3.1. Insights
          • 3.7.3.2. Key Takeaways
        • 3.7.4. Gastrointestinal Tract Infections
          • 3.7.4.1. Insights
          • 3.7.4.2. Key Takeaways
        • 3.7.5. HPV
          • 3.7.5.1. Insights
          • 3.7.5.2. Key Takeaways
        • 3.7.6. Sexually Transmitted Infections
          • 3.7.6.1. Insights
          • 3.7.6.2. Key Takeaways
        • 3.7.7. Sepsis
          • 3.7.7.1. Insights
          • 3.7.7.2. Key Takeaways
        • 3.7.8. Drug Resistance Diseases
          • 3.7.8.1. Insights
          • 3.7.8.2. Key Takeaways
        • 3.7.9. Other Infectious Diseases
          • 3.7.9.1. Insights
          • 3.7.9.2. Key Takeaways
      • 3.8. Global Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
      • 3.9. Global Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By End-User
        • 3.9.1. Hospitals
          • 3.9.1.1. Insights
          • 3.9.1.2. Key Takeaways
        • 3.9.2. Clinics and Outpatient Diagnostic Centres
          • 3.9.2.1. Insights
          • 3.9.2.2. Key Takeaways
        • 3.9.3. Diagnostic Laboratories
          • 3.9.3.1. Insights
          • 3.9.3.2. Key Takeaways
        • 3.9.4. Research Institutes
          • 3.9.4.1. Insights
          • 3.9.4.2. Key Takeaways
    • 4. Global Infectious Disease Molecular Diagnostics Market Analysis and Forecast, By Region, 2020-2034
      • 4.1. Key Findings
      • 4.2. Global Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
        • 4.2.1. North America
          • 4.2.1.1. Regional Insights
        • 4.2.2. Europe
          • 4.2.2.1. Regional Insights
        • 4.2.3. Asia Pacific
          • 4.2.3.1. Regional Insights
        • 4.2.4. Latin America
          • 4.2.4.1. Regional Insights
        • 4.2.5. Middle East & Africa
          • 4.2.5.1. Regional Insights
      • 4.3. Global Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Region
    • 5. North America Infectious Disease Molecular Diagnostics Market Analysis and Forecast, 2020-2034
      • 5.1. Key Findings
      • 5.2. North America Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
      • 5.3. North America Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Product
      • 5.4. North America Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 5.5. North America Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Technology
      • 5.6. North America Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 5.7. North America Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Application
      • 5.8. North America Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
      • 5.9. North America Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By End-User
      • 5.10. North America Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 5.11. North America Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Country
        • 5.11.1. The US
        • 5.11.2. Canada
    • 6. Europe Infectious Disease Molecular Diagnostics Market Analysis and Forecast, 2020-2034
      • 6.1. Key Findings
      • 6.2. Europe Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
      • 6.3. Europe Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Product
      • 6.4. Europe Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 6.5. Europe Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Technology
      • 6.6. Europe Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 6.7. Europe Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Application
      • 6.8. Europe Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
      • 6.9. Europe Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By End-User
      • 6.10. Europe Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 6.11. Europe Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Country
        • 6.11.1. Germany
        • 6.11.2. The UK
        • 6.11.3. France
        • 6.11.4. Spain
        • 6.11.5. Italy
        • 6.11.6. Russia
        • 6.11.7. Netherland
        • 6.11.8. Rest of Europe
    • 7. Asia Pacific Infectious Disease Molecular Diagnostics Market Analysis and Forecast, 2020-2034
      • 7.1. Key Findings
      • 7.2. Asia Pacific Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
      • 7.3. Asia Pacific Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Product
      • 7.4. Asia Pacific Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 7.5. Asia Pacific Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Technology
      • 7.6. Asia Pacific Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 7.7. Asia Pacific Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Application
      • 7.8. Asia Pacific Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
      • 7.9. Asia Pacific Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By End-User
      • 7.10. Asia Pacific Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 7.11. Asia Pacific Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Country
        • 7.11.1. China
        • 7.11.2. Japan
        • 7.11.3. South Korea
        • 7.11.4. India
        • 7.11.5. Australia
        • 7.11.6. New Zealand
        • 7.11.7. Singapore
        • 7.11.8. Thailand
        • 7.11.9. Vietnam
        • 7.11.10. Rest of Asia Pacific
    • 8. Latin America Infectious Disease Molecular Diagnostics Market Analysis and Forecast, 2020-2034
      • 8.1. Key Findings
      • 8.2. Latin America Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
      • 8.3. Latin America Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Product
      • 8.4. Latin America Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 8.5. Latin America Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Technology
      • 8.6. Latin America Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 8.7. Latin America Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Application
      • 8.8. Latin America Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
      • 8.9. Latin America Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By End-User
      • 8.10. Latin America Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 8.11. Latin America Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Country
        • 8.11.1. Brazil
        • 8.11.2. Mexico
        • 8.11.3. Rest of Latin America
    • 9. Middle East & Africa Infectious Disease Molecular Diagnostics Market Analysis and Forecast, 2020-2034
      • 9.1. Key Findings
      • 9.2. Middle East & Africa Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
      • 9.3. Middle East & Africa Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Product
      • 9.4. Middle East & Africa Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 9.5. Middle East & Africa Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Technology
      • 9.6. Middle East & Africa Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 9.7. Middle East & Africa Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Application
      • 9.8. Middle East & Africa Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
      • 9.9. Middle East & Africa Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By End-User
      • 9.10. Middle East & Africa Infectious Disease Molecular Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 9.11. Middle East & Africa Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Country
        • 9.11.1. South Africa
        • 9.11.2. Saudi Arabia
        • 9.11.3. UAE
        • 9.11.4. Rest of Middle East & Africa
    • 10. Competitive Landscape & Company Profiles
      • 10.1. Market Competition Scenario Analysis, By Company
        • 10.1.1. Key Takeaways
      • 10.2. Overview of Major Market Players
      • 10.3. Competitor Landscape
      • 10.4. Strategic Mapping
      • 10.5. Company Life Cycle Analysis
      • 10.6. Company Market Share Analysis
      • 10.7. Company Profiles
        • 10.7.1. F. Hoffmann‑La Roche Ltd. (Roche)
          • 10.7.1.1. Company Details
          • 10.7.1.2. Business Overview
          • 10.7.1.3. Product Portfolio
          • 10.7.1.4. Financial Insights
          • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.1.6. SWOT Analysis
          • 10.7.1.7. Geographic Footprint
        • 10.7.2. Abbott Laboratories
          • 10.7.2.1. Company Details
          • 10.7.2.2. Business Overview
          • 10.7.2.3. Product Portfolio
          • 10.7.2.4. Financial Insights
          • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.2.6. SWOT Analysis
          • 10.7.2.7. Geographic Footprint
        • 10.7.3. Danaher Corporation (including its subsidiary Cepheid)
          • 10.7.3.1. Company Details
          • 10.7.3.2. Business Overview
          • 10.7.3.3. Product Portfolio
          • 10.7.3.4. Financial Insights
          • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.3.6. SWOT Analysis
          • 10.7.3.7. Geographic Footprint
        • 10.7.4. bioMérieux SA
          • 10.7.4.1. Company Details
          • 10.7.4.2. Business Overview
          • 10.7.4.3. Product Portfolio
          • 10.7.4.4. Financial Insights
          • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.4.6. SWOT Analysis
          • 10.7.4.7. Geographic Footprint
        • 10.7.5. Thermo Fisher Scientific Inc.
          • 10.7.5.1. Company Details
          • 10.7.5.2. Business Overview
          • 10.7.5.3. Product Portfolio
          • 10.7.5.4. Financial Insights
          • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.5.6. SWOT Analysis
          • 10.7.5.7. Geographic Footprint
        • 10.7.6. Siemens Healthineers AG
          • 10.7.6.1. Company Details
          • 10.7.6.2. Business Overview
          • 10.7.6.3. Product Portfolio
          • 10.7.6.4. Financial Insights
          • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.6.6. SWOT Analysis
          • 10.7.6.7. Geographic Footprint
        • 10.7.7. Becton, Dickinson and Company (BD)
          • 10.7.7.1. Company Details
          • 10.7.7.2. Business Overview
          • 10.7.7.3. Product Portfolio
          • 10.7.7.4. Financial Insights
          • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.7.6. SWOT Analysis
          • 10.7.7.7. Geographic Footprint
        • 10.7.8. Hologic Inc.
          • 10.7.8.1. Company Details
          • 10.7.8.2. Business Overview
          • 10.7.8.3. Product Portfolio
          • 10.7.8.4. Financial Insights
          • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.8.6. SWOT Analysis
          • 10.7.8.7. Geographic Footprint
        • 10.7.9. QIAGEN N.V.
          • 10.7.9.1. Company Details
          • 10.7.9.2. Business Overview
          • 10.7.9.3. Product Portfolio
          • 10.7.9.4. Financial Insights
          • 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.9.6. SWOT Analysis
          • 10.7.9.7. Geographic Footprint
        • 10.7.10. Grifols S.A.
          • 10.7.10.1. Company Details
          • 10.7.10.2. Business Overview
          • 10.7.10.3. Product Portfolio
          • 10.7.10.4. Financial Insights
          • 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.10.6. SWOT Analysis
          • 10.7.10.7. Geographic Footprint
        • 10.7.11. DiaSorin S.p.A.
          • 10.7.11.1. Company Details
          • 10.7.11.2. Business Overview
          • 10.7.11.3. Product Portfolio
          • 10.7.11.4. Financial Insights
          • 10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.11.6. SWOT Analysis
          • 10.7.11.7. Geographic Footprint
        • 10.7.12. Seegene Inc.
          • 10.7.12.1. Company Details
          • 10.7.12.2. Business Overview
          • 10.7.12.3. Product Portfolio
          • 10.7.12.4. Financial Insights
          • 10.7.12.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.12.6. SWOT Analysis
          • 10.7.12.7. Geographic Footprint
        • 10.7.13. Bio‑Rad Laboratories Inc.
          • 10.7.13.1. Company Details
          • 10.7.13.2. Business Overview
          • 10.7.13.3. Product Portfolio
          • 10.7.13.4. Financial Insights
          • 10.7.13.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.13.6. SWOT Analysis
          • 10.7.13.7. Geographic Footprint
        • 10.7.14. Quest Diagnostics Incorporated
          • 10.7.14.1. Company Details
          • 10.7.14.2. Business Overview
          • 10.7.14.3. Product Portfolio
          • 10.7.14.4. Financial Insights
          • 10.7.14.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.14.6. SWOT Analysis
          • 10.7.14.7. Geographic Footprint
    • 11. Methodology and Data Source
      • 11.1. Methodology/Research Approach
      • 11.2. Market Size Estimation
      • 11.3. Market Breakdown and Data Triangulation
      • 11.4. Data Source
      • 11.5. Secondary Sources
      • 11.6. Primary Sources
      • 11.7. Appendix
      • 11.8. Disclaimer
    • List of Tables
      • Table 1. Global Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 2. Global Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 3. Global Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 4. Global Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 5. Global Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Region, 2020-2034
      • Table 6. North America Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 7. North America Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 8. North America Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 9. North America Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 10. North America Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Country, 2020-2034
      • Table 11. The US Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 12. The US Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 13. The US Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 14. The US Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 15. Canada Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 16. Canada Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 17. Canada Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 18. Canada Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 19. Europe Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 20. Europe Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 21. Europe Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 22. Europe Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 23. Europe Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Country, 2020-2034
      • Table 24. Germany Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 25. Germany Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 26. Germany Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 27. Germany Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 28. The UK Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 29. The UK Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 30. The UK Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 31. The UK Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 32. France Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 33. France Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 34. France Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 35. France Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 36. Spain Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 37. Spain Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 38. Spain Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 39. Spain Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 40. Italy Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 41. Italy Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 42. Italy Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 43. Italy Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 44. Russia Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 45. Russia Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 46. Russia Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 47. Russia Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 48. Netherland Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 49. Netherland Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 50. Netherland Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 51. Netherland Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 52. Rest of Europe Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 53. Rest of Europe Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 54. Rest of Europe Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 55. Rest of Europe Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 56. Asia Pacific Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 57. Asia Pacific Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 58. Asia Pacific Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 59. Asia Pacific Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 60. Asia Pacific Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Country, 2020-2034
      • Table 61. China Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 62. China Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 63. China Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 64. China Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 65. India Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 66. India Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 67. India Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 68. India Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 69. Japan Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 70. Japan Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 71. Japan Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 72. Japan Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 73. South Korea Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 74. South Korea Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 75. South Korea Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 76. South Korea Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 77. Australia Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 78. Australia Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 79. Australia Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 80. Australia Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 81. New Zealand Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 82. New Zealand Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 83. New Zealand Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 84. New Zealand Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 85. Singapore Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 86. Singapore Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 87. Singapore Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 88. Singapore Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 89. Thailand Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 90. Thailand Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 91. Thailand Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 92. Thailand Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 93. Vietnam Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 94. Vietnam Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 95. Vietnam Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 96. Vietnam Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 97. Rest of Asia Pacific Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 98. Rest of Asia Pacific Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 99. Rest of Asia Pacific Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 100. Rest of Asia Pacific Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 101. Latin America Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 102. Latin America Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 103. Latin America Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 104. Latin America Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 105. Latin America Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Country, 2020-2034
      • Table 106. Brazil Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 107. Brazil Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 108. Brazil Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 109. Brazil Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 110. Mexico Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 111. Mexico Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 112. Mexico Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 113. Mexico Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 114. Rest of Latin America Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 115. Rest of Latin America Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 116. Rest of Latin America Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 117. Rest of Latin America Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 118. Middle East & Africa Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 119. Middle East & Africa Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 120. Middle East & Africa Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 121. Middle East & Africa Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 122. Middle East & Africa Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Country, 2020-2034
      • Table 123. South Africa Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 124. South Africa Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 125. South Africa Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 126. South Africa Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 127. Saudi Arabia Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 128. Saudi Arabia Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 129. Saudi Arabia Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 130. Saudi Arabia Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 131. UAE Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 132. UAE Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 133. UAE Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 134. UAE Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
      • Table 135. Rest of Middle East & Africa Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Product, 2020-2034
      • Table 136. Rest of Middle East & Africa Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Technology, 2020-2034
      • Table 137. Rest of Middle East & Africa Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By Application, 2020-2034
      • Table 138. Rest of Middle East & Africa Infectious Disease Molecular Diagnostics Market Value (US$ Mn), By End-User, 2020-2034
    • List of Figures
      • Figure 1. Global Infectious Disease Molecular Diagnostics Market Snapshot: Market Value (US$ Mn), 2020-2034
      • Figure 2. Opportunity Map
      • Figure 3. Opportunity Orbit
      • Figure 4. Regional Market Share and BPS Analysis in Infectious Disease Molecular Diagnostics Market
      • Figure 5. Global Infectious Disease Molecular Diagnostics Market Analysis, By Product, 2020, 2024 and 2034
      • Figure 6. Global Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Product
      • Figure 7. Global Infectious Disease Molecular Diagnostics Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 8. Global Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Technology
      • Figure 9. Global Infectious Disease Molecular Diagnostics Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 10. Global Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Application
      • Figure 11. Global Infectious Disease Molecular Diagnostics Market Analysis, By End-User, 2020, 2024 and 2034
      • Figure 12. Global Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By End-User
      • Figure 13. Global Infectious Disease Molecular Diagnostics Market Analysis, By Region, 2020, 2024 and 2034
      • Figure 14. Global Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Region
      • Figure 15. North America Infectious Disease Molecular Diagnostics Market Analysis, By Product, 2020, 2024 and 2034
      • Figure 16. North America Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Product
      • Figure 17. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Instruments, 2020-2034
      • Figure 18. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Reagents & Kits, 2020-2034
      • Figure 19. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Services, 2020-2034
      • Figure 20. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Others, 2020-2034
      • Figure 21. North America Infectious Disease Molecular Diagnostics Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 22. North America Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Technology
      • Figure 23. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 24. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by In Situ Hybridization (ISH), 2020-2034
      • Figure 25. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Figure 26. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Chips & Microarrays, 2020-2034
      • Figure 27. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Mass Spectrometry, 2020-2034
      • Figure 28. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Sequencing, 2020-2034
      • Figure 29. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Transcription Mediated Amplification (TMA), 2020-2034
      • Figure 30. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Others, 2020-2034
      • Figure 31. North America Infectious Disease Molecular Diagnostics Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 32. North America Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Application
      • Figure 33. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Respiratory Diseases, 2020-2034
      • Figure 34. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Tuberculosis, 2020-2034
      • Figure 35. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Meningitis, 2020-2034
      • Figure 36. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Gastrointestinal Tract Infections, 2020-2034
      • Figure 37. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by HPV, 2020-2034
      • Figure 38. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Sexually Transmitted Infections, 2020-2034
      • Figure 39. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Sepsis, 2020-2034
      • Figure 40. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Drug Resistance Diseases, 2020-2034
      • Figure 41. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Other Infectious Diseases, 2020-2034
      • Figure 42. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Respiratory Diseases0, 2020-2034
      • Figure 43. North America Infectious Disease Molecular Diagnostics Market Analysis, By End-User, 2020, 2024 and 2034
      • Figure 44. North America Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By End-User
      • Figure 45. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 46. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Clinics and Outpatient Diagnostic Centres, 2020-2034
      • Figure 47. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Diagnostic Laboratories, 2020-2034
      • Figure 48. North America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Research Institutes, 2020-2034
      • Figure 49. North America Infectious Disease Molecular Diagnostics Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 50. North America Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Country
      • Figure 51. Europe Infectious Disease Molecular Diagnostics Market Analysis, By Product, 2020, 2024 and 2034
      • Figure 52. Europe Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Product
      • Figure 53. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by Instruments, 2020-2034
      • Figure 54. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by Reagents & Kits, 2020-2034
      • Figure 55. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by Services, 2020-2034
      • Figure 56. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by Others, 2020-2034
      • Figure 57. Europe Infectious Disease Molecular Diagnostics Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 58. Europe Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Technology
      • Figure 59. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 60. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by In Situ Hybridization (ISH), 2020-2034
      • Figure 61. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Figure 62. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by Chips & Microarrays, 2020-2034
      • Figure 63. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by Mass Spectrometry, 2020-2034
      • Figure 64. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by Sequencing, 2020-2034
      • Figure 65. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by Transcription Mediated Amplification (TMA), 2020-2034
      • Figure 66. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by Others, 2020-2034
      • Figure 67. Europe Infectious Disease Molecular Diagnostics Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 68. Europe Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Application
      • Figure 69. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by Respiratory Diseases, 2020-2034
      • Figure 70. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by Tuberculosis, 2020-2034
      • Figure 71. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by Meningitis, 2020-2034
      • Figure 72. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by Gastrointestinal Tract Infections, 2020-2034
      • Figure 73. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by HPV, 2020-2034
      • Figure 74. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by Sexually Transmitted Infections, 2020-2034
      • Figure 75. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by Sepsis, 2020-2034
      • Figure 76. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by Drug Resistance Diseases, 2020-2034
      • Figure 77. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by Other Infectious Diseases, 2020-2034
      • Figure 78. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by Respiratory Diseases0, 2020-2034
      • Figure 79. Europe Infectious Disease Molecular Diagnostics Market Analysis, By End-User, 2020, 2024 and 2034
      • Figure 80. Europe Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By End-User
      • Figure 81. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 82. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by Clinics and Outpatient Diagnostic Centres, 2020-2034
      • Figure 83. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by Diagnostic Laboratories, 2020-2034
      • Figure 84. Europe Infectious Disease Molecular Diagnostics Market (US$ Mn), by Research Institutes, 2020-2034
      • Figure 85. Europe Infectious Disease Molecular Diagnostics Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 86. Europe Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Country
      • Figure 87. Asia Pacific Infectious Disease Molecular Diagnostics Market Analysis, By Product, 2020, 2024 and 2034
      • Figure 88. Asia Pacific Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Product
      • Figure 89. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by Instruments, 2020-2034
      • Figure 90. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by Reagents & Kits, 2020-2034
      • Figure 91. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by Services, 2020-2034
      • Figure 92. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by Others, 2020-2034
      • Figure 93. Asia Pacific Infectious Disease Molecular Diagnostics Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 94. Asia Pacific Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Technology
      • Figure 95. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 96. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by In Situ Hybridization (ISH), 2020-2034
      • Figure 97. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Figure 98. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by Chips & Microarrays, 2020-2034
      • Figure 99. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by Mass Spectrometry, 2020-2034
      • Figure 100. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by Sequencing, 2020-2034
      • Figure 101. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by Transcription Mediated Amplification (TMA), 2020-2034
      • Figure 102. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by Others, 2020-2034
      • Figure 103. Asia Pacific Infectious Disease Molecular Diagnostics Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 104. Asia Pacific Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Application
      • Figure 105. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by Respiratory Diseases, 2020-2034
      • Figure 106. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by Tuberculosis, 2020-2034
      • Figure 107. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by Meningitis, 2020-2034
      • Figure 108. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by Gastrointestinal Tract Infections, 2020-2034
      • Figure 109. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by HPV, 2020-2034
      • Figure 110. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by Sexually Transmitted Infections, 2020-2034
      • Figure 111. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by Sepsis, 2020-2034
      • Figure 112. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by Drug Resistance Diseases, 2020-2034
      • Figure 113. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by Other Infectious Diseases, 2020-2034
      • Figure 114. Asia Pacific Infectious Disease Molecular Diagnostics Market Analysis, By End-User, 2020, 2024 and 2034
      • Figure 115. Asia Pacific Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By End-User
      • Figure 116. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 117. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by Clinics and Outpatient Diagnostic Centres, 2020-2034
      • Figure 118. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by Diagnostic Laboratories, 2020-2034
      • Figure 119. Asia Pacific Infectious Disease Molecular Diagnostics Market (US$ Mn), by Research Institutes, 2020-2034
      • Figure 120. Asia Pacific Infectious Disease Molecular Diagnostics Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 121. Asia Pacific Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Country
      • Figure 122. Latin America Infectious Disease Molecular Diagnostics Market Analysis, By Product, 2020, 2024 and 2034
      • Figure 123. Latin America Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Product
      • Figure 124. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Instruments, 2020-2034
      • Figure 125. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Reagents & Kits, 2020-2034
      • Figure 126. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Services, 2020-2034
      • Figure 127. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Others, 2020-2034
      • Figure 128. Latin America Infectious Disease Molecular Diagnostics Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 129. Latin America Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Technology
      • Figure 130. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 131. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by In Situ Hybridization (ISH), 2020-2034
      • Figure 132. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Figure 133. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Chips & Microarrays, 2020-2034
      • Figure 134. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Mass Spectrometry, 2020-2034
      • Figure 135. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Sequencing, 2020-2034
      • Figure 136. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Transcription Mediated Amplification (TMA), 2020-2034
      • Figure 137. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Others, 2020-2034
      • Figure 138. Latin America Infectious Disease Molecular Diagnostics Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 139. Latin America Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Application
      • Figure 140. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Respiratory Diseases, 2020-2034
      • Figure 141. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Tuberculosis, 2020-2034
      • Figure 142. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Meningitis, 2020-2034
      • Figure 143. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Gastrointestinal Tract Infections, 2020-2034
      • Figure 144. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by HPV, 2020-2034
      • Figure 145. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Sexually Transmitted Infections, 2020-2034
      • Figure 146. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Sepsis, 2020-2034
      • Figure 147. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Drug Resistance Diseases, 2020-2034
      • Figure 148. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Other Infectious Diseases, 2020-2034
      • Figure 149. Latin America Infectious Disease Molecular Diagnostics Market Analysis, By End-User, 2020, 2024 and 2034
      • Figure 150. Latin America Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By End-User
      • Figure 151. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 152. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Clinics and Outpatient Diagnostic Centres, 2020-2034
      • Figure 153. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Diagnostic Laboratories, 2020-2034
      • Figure 154. Latin America Infectious Disease Molecular Diagnostics Market (US$ Mn), by Research Institutes, 2020-2034
      • Figure 155. Latin America Infectious Disease Molecular Diagnostics Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 156. Latin America Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Country
      • Figure 157. Middle East & Africa Infectious Disease Molecular Diagnostics Market Analysis, By Product, 2020, 2024 and 2034
      • Figure 158. Middle East & Africa Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Product
      • Figure 159. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by Instruments, 2020-2034
      • Figure 160. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by Reagents & Kits, 2020-2034
      • Figure 161. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by Services, 2020-2034
      • Figure 162. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by Others, 2020-2034
      • Figure 163. Middle East & Africa Infectious Disease Molecular Diagnostics Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 164. Middle East & Africa Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Technology
      • Figure 165. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 166. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by In Situ Hybridization (ISH), 2020-2034
      • Figure 167. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Figure 168. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by Chips & Microarrays, 2020-2034
      • Figure 169. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by Mass Spectrometry, 2020-2034
      • Figure 170. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by Sequencing, 2020-2034
      • Figure 171. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by Transcription Mediated Amplification (TMA), 2020-2034
      • Figure 172. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by Others, 2020-2034
      • Figure 173. Middle East & Africa Infectious Disease Molecular Diagnostics Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 174. Middle East & Africa Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Application
      • Figure 175. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by Respiratory Diseases, 2020-2034
      • Figure 176. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by Tuberculosis, 2020-2034
      • Figure 177. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by Meningitis, 2020-2034
      • Figure 178. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by Gastrointestinal Tract Infections, 2020-2034
      • Figure 179. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by HPV, 2020-2034
      • Figure 180. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by Sexually Transmitted Infections, 2020-2034
      • Figure 181. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by Sepsis, 2020-2034
      • Figure 182. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by Drug Resistance Diseases, 2020-2034
      • Figure 183. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by Other Infectious Diseases, 2020-2034
      • Figure 184. Middle East & Africa Infectious Disease Molecular Diagnostics Market Analysis, By End-User, 2020, 2024 and 2034
      • Figure 185. Middle East & Africa Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By End-User
      • Figure 186. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by Hospitals, 2020-2034
      • Figure 187. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by Clinics and Outpatient Diagnostic Centres, 2020-2034
      • Figure 188. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by Diagnostic Laboratories, 2020-2034
      • Figure 189. Middle East & Africa Infectious Disease Molecular Diagnostics Market (US$ Mn), by Research Institutes, 2020-2034
      • Figure 190. Middle East & Africa Infectious Disease Molecular Diagnostics Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 191. Middle East & Africa Infectious Disease Molecular Diagnostics Market Attractiveness Analysis, By Country
    • F. Hoffmann‑La Roche Ltd. (Roche)
    • Abbott Laboratories
    • Danaher Corporation (including its subsidiary Cepheid)
    • bioMérieux SA
    • Thermo Fisher Scientific Inc.
    • Siemens Healthineers AG
    • Becton, Dickinson and Company (BD)
    • Hologic Inc.
    • QIAGEN N.V.
    • Grifols S.A.
    • DiaSorin S.p.A.
    • Seegene Inc.
    • Bio‑Rad Laboratories Inc.
    • Quest Diagnostics Incorporated
Infectious Disease Molecular Diagnostics Market
Infectious Disease Molecular Diagnostics Market
Published date: Oct 2025
add_shopping_cartBuy Now get_appDownload Sample

Related Reports

Infectious Disease Molecular Diagnostics Market
  • 163576
  • Oct 2025
    • ★★★★★
      ★★★★★
Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo
  • Client Logo

Our Clients

✖
Request a Sample Report
We'll get back to you as quickly as possible

✖
Request a Sample Report
We'll get back to you as quickly as possible

Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options